SRx Health Solutions filed an S-1 to register the resale of up to 82,000,000 shares by Keystone Capital Partners, LLC, valued up to $26.6 million, providing no proceeds to the company. Investor confidence is severely hampered by an auditor citing substantial doubt regarding SRXH’s ability to continue as a going concern due to capital needs and persistent operating losses.
CRITICAL CRISIS & SUBSEQUENT EVENTS: The core Canadian specialty pharmacy subsidiary (SRx Canada) filed for CCAA creditor protection in August 2025, signaling severe distress. This event led to the write-off of an $8.6 m
...